| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Eli Lilly is at the forefront of advancements in obesity treatment and drug innovation, particularly with their next-generation drug retatrutide, which shows promise in managing Type 2 diabetes and weight control. The company's commitment to expanding its product portfolio is reflected in the positive patient outcomes and the development of new anti-obesity medications. This focus on innovative therapeutic solutions positions Eli Lilly favorably in the competitive pharmaceutical landscape. However, challenges remain, such as the inherent risks associated with drug development and market acceptance of new therapies. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -3.5 is extremely bearish. The market sentiment at -0.7 is bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. LLY is likely to move down since both trend sentiment and market sentiment are negative. The positive sentiment force for sector is at 0.3, and the negative at -1 on 2026-03-23. The forces of Stock Price Trend (-3.5), Sector Price Trend (-2), Market Risk Appetite (-1), and Valuation Sentiment (-0.6) will drive down the price. The forces of Price Level Sentiment (0.5), Sentiment towards Fundamentals (0.7), and Option Sentiment (0.8) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| LLY | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-23 | 0%(0.1%) | 910.54 | 4.78% | 8 | 0.44% | -1.02% | -3.5 | -0.2 | 0.5% | -0.7 | Short | 55% | 0.7 | 4.5 |
| 2026-03-22 | 0%(0.1%) | -3.1 | -0.2 | -0.8 | 0.7 | -1 | ||||||||
| 2026-03-21 | 0%(0.1%) | -3.1 | -0.2 | -0.7 | 0.5 | -1 | ||||||||
| 2026-03-20 | 0%(0.1%) | 906.59 | 4.73% | 0 | -1.21% | -0.85% | -3.1 | -0.4 | 0.6% | -0.6 | Short | 70% | 0.4 | -1 |
| 2026-03-19 | 0%(0.1%) | 917.68 | 4.17% | -2 | -0.03% | -0.66% | -2.4 | -0.5 | 1.7% | -0.5 | Short | 70% | 0.2 | 5.8 |
| 2026-03-18 | 0%(0.1%) | 917.93 | 3.7% | -12 | -1.35% | -0.86% | -3.1 | -0.5 | 3.3% | -0.7 | Short | 70% | -1.6 | 4 |
| 2026-03-17 | 1%(0.1%) | 930.51 | 3.02% | -18 | -5.89% | -0.77% | -2.7 | -1.5 | 2.5% | -0.3 | Short | 60% | -0.4 | -5.6 |
| 2026-03-16 | 0%(0%) | 988.79 | 2.28% | 23 | 0.34% | -0.28% | -1 | 0.2 | 0.6% | 0.3 | Wait | 50% | 2.2 | -5 |
| 2026-03-15 | 0%(0%) | -1.1 | 0.2 | 0.5 | 1.7 | -1 | ||||||||
| 2026-03-14 | 0%(0%) | -1.1 | 0.2 | 0.4 | 1.5 | -1 | ||||||||
| Short is the preferred trading strategy with 55% chance of being right. Weak trend sentiment and negative hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| Analysis | ||
| ● Eli Lilly (LLY) – Equity Research Report Tue. Mar 17, 2026 | ||
| 2026-03-23 17:02:11 Wealth management firms are strategically acquiring additional shares in Eli Lilly, suggesting a bullish outlook on the company's future. |
| 2026-03-23 17:02:11 The mentions of recent SEC filings by various investment firms indicate ongoing regulatory oversight and compliance in corporate investments. |
| 2026-03-23 17:02:11 The corporate interest in the Chinese market highlights a broader trend of companies looking to expand in emerging markets. |
| 2026-03-23 17:02:11 Eli Lilly's stock shows resilience with a modest gain, reflecting a stable market position amidst ongoing economic challenges. |
| 2026-03-23 17:02:11 Several institutional investors are increasing their stakes in Eli Lilly, indicating confidence in the company's growth potential. |
| 2026-03-23 15:49:18 Eli Lilly's ramped investments suggest a strong commitment to growth and innovation within their operational strategy. |
| 2026-03-23 15:49:18 The revival of Actos litigation risks presents potential legal challenges to Eli Lilly that could impact their operations and reputation. |
| 2026-03-23 15:49:18 The overall cautious approach of global CEOs towards expansion in China amidst ongoing investments by Eli Lilly indicates a significant industry trend. |
| 2026-03-23 11:49:02 Analysts are positively revising their views on Eli Lilly's stock based on its recent performance. |
| 2026-03-23 11:49:02 The article highlights the impact of Eli Lilly's strong quarterly earnings on stock upgrades from analysts. |
| 2026-03-23 11:49:02 Eli Lilly's stock is showing positive performance following strong quarterly results, leading to upgrades from analysts. |